Mitochondrial behavior and localization in reconstituted oocytes derived from germinal vesicle transfer

Human Cell
Mamoru Kobayashi, Kahei Sato

Abstract

We investigated the mitochondrial behavior, localization and heteroplasmy in reconstituted oocytes derived from germinal vesicle (GV) transfers. The karyoplast containing the GV nucleus and the ooplast (enucleated oocyte) were prepared from GV oocytes derived from B6D2F1 mice. Mitochondria in the karyoplast and ooplast were labeled with MitoRed (Dojindo Laboratories, Kummoto, Japan) and MitoTracker Green (Molecular Probes, Eugene, OR, USA), respectively. After labeling the mitochondria, the karyoplast and ooplast were paired and fused. The mitochondrial behavior in fused (reconstituted) oocytes during in vitro maturation and preimplantation development were observed using confocal laser-scanning microscopy. In reconstituted oocytes that had reached to the M-II stage, mitochondria localized and concentrated in the hemispherical area of oocytes containing the M-II spindle. We showed that the two types of mitochondria derived from the GV donor and the recipient in reconstituted oocytes exhibit similar behavior to the normal oocyte during meiosis, and that the mitochondrial heteroplasmy of these oocytes did not influence their in vitro maturation and preimplantation development.

References

Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·J Van Blerkom
Jan 1, 1995·Developmental Genetics·P G Calarco
Oct 21, 2000·Human Reproduction·J A BarrittJ Cohen
Mar 3, 2001·Human Reproduction·J A BarrittJ Cohen
Mar 30, 2001·Human Reproduction·T TakeuchiG D Palermo
Apr 2, 2002·Human Reproduction·Susan M HawesKeith E Latham

❮ Previous
Next ❯

Citations

Nov 1, 2016·The Journal of Reproduction and Development·Thanh Quang Dang-NguyenKazuhiro Kikuchi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.